CARSON LISA CABOTT (Chief Financial Officer) reported 1 transaction at PHIO PHARMACEUTICALS CORP.
Review the transaction codes below to understand the nature of each event.
Filed: 9/15/2026ACC: 0001683168-26-007158
Officer· Chief Financial Officer
Since Feb 2026
-12.89K
Net shares
Net seller
$13.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
12.89K disposed
Non-Derivative Transactions1
Common Stock, $.0001 par value
Direct
Shares
−12.89K
Price / share
$1.03
Trade value
$13.27K
% of position
13.7%
9/11/2026
94K→81.11K
Total
Net shares
−12.89K
Net value
-$13.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 par value Direct | 9/11/2026 | F · Tax Withholding | −12.89K | $1.03 | $13.27K | 13.7% | 94K | 81.11K |
| Total | −12.89K | -$13.27K | ||||||
Derivative Transactions0
No derivative transactions reported